Resources

Relevant, timely and evidence-based information for Australian health professionals and consumers.

We have many resources available for consumers and health professionals including brochures, fact sheets and translated resources. All of our products are available free of charge.

Corporate documents

Annual reports, budgets, corporate plans, reports

Clinical resources

Fact sheets, action plans, brochures, guidelines, and more for health professionals and consumers

Multimedia

Videos, podcasts, conference recordings, images and Infographics

 

Filter

Sort by:
empty empty

Episode 42: Exploring digital interventions for mental health

  • 19 May 2022
  • Podcasts

Episode 42: Exploring digital interventions for mental health

  • 19 May 2022
  • Podcasts

In this episode, NPS MedicineWise medical advisor Dr Caroline West speaks with Dr Michael Millard, director of the clinical research unit for anxiety and depression at St. Vincent's Hospital. They discuss how early interventions with effective support, engagement and management of course can make all the difference to young people and their mental health.




Further reading

NPS MedicineWise Mental health and young people: opportunities to empower and engage

NPS MedicineWise podcast Mental health and young people: two personal stories

This Way Up thiswayup.org.au


Immunoglobulin replacement therapy for acquired hypogammaglobulinaemia secondary to haematological malignancies and stem cell transplantation Immunoglobulin replacement therapy for acquired hypogammaglobulinaemia secondary to haematological malignancies and stem cell transplantation

Immunoglobulin replacement therapy for acquired hypogammaglobulinaemia secondary to haematological malignancies and stem cell transplantation

  • 16 June 2022
  • Clinical algorithms and tools

Immunoglobulin replacement therapy for acquired hypogammaglobulinaemia secondary to haematological malignancies and stem cell transplantation

  • 16 June 2022
  • Clinical algorithms and tools
Myasthenia gravis – Value in Prescribing Immunoglobulin products Myasthenia gravis – Value in Prescribing Immunoglobulin products

Myasthenia gravis – Value in Prescribing Immunoglobulin products

  • 14 June 2022
  • Clinical algorithms and tools

Myasthenia gravis – Value in Prescribing Immunoglobulin products

  • 14 June 2022
  • Clinical algorithms and tools
Immunoglobulin management and wellbeing plan Immunoglobulin management and wellbeing plan

Immunoglobulin management and wellbeing plan

  • 6 June 2022
  • Patient action plans

Immunoglobulin management and wellbeing plan

  • 6 June 2022
  • Patient action plans
Immunoglobulin dose adjustment, weaning and cessation: a conversation guide for health professionals Immunoglobulin dose adjustment, weaning and cessation: a conversation guide for health professionals

Immunoglobulin dose adjustment, weaning and cessation: a conversation guide for health professionals

  • 16 June 2022
  • Clinical algorithms and tools

Immunoglobulin dose adjustment, weaning and cessation: a conversation guide for health professionals

  • 16 June 2022
  • Clinical algorithms and tools
Immunoglobulin management and wellbeing plan Immunoglobulin management and wellbeing plan

Immunoglobulin management and wellbeing plan

  • 6 June 2022
  • Patient action plans

Immunoglobulin management and wellbeing plan

  • 6 June 2022
  • Patient action plans
Immunoglobulin products: when to reduce or stop treatment This action plan informs and empowers patients to participate in changes to their treatment. Immunoglobulin products: when to reduce or stop treatment This action plan informs and empowers patients to participate in changes to their treatment.

Immunoglobulin products: when to reduce or stop treatment This action plan informs and empowers patients to participate in changes to their treatment.

  • 15 June 2022
  • Clinical algorithms and tools

Immunoglobulin products: when to reduce or stop treatment This action plan informs and empowers patients to participate in changes to their treatment.

  • 15 June 2022
  • Clinical algorithms and tools
Immunoglobulin products: when to reduce or stop treatment This action plan informs and empowers patients to participate in changes to their treatment. Immunoglobulin products: when to reduce or stop treatment This action plan informs and empowers patients to participate in changes to their treatment.

Immunoglobulin products: when to reduce or stop treatment This action plan informs and empowers patients to participate in changes to their treatment.

  • 15 June 2022
  • Clinical algorithms and tools

Immunoglobulin products: when to reduce or stop treatment This action plan informs and empowers patients to participate in changes to their treatment.

  • 15 June 2022
  • Clinical algorithms and tools
Immunoglobulin products: when to reduce or stop treatment Immunoglobulin products: when to reduce or stop treatment

Immunoglobulin products: when to reduce or stop treatment

  • 15 June 2022
  • Clinical algorithms and tools

Immunoglobulin products: when to reduce or stop treatment

  • 15 June 2022
  • Clinical algorithms and tools
Immunoglobulin dose adjustment, weaning and cessation: a conversation guide for health professionals Immunoglobulin dose adjustment, weaning and cessation: a conversation guide for health professionals

Immunoglobulin dose adjustment, weaning and cessation: a conversation guide for health professionals

  • 16 June 2022
  • Clinical algorithms and tools

Immunoglobulin dose adjustment, weaning and cessation: a conversation guide for health professionals

  • 16 June 2022
  • Clinical algorithms and tools